202 related articles for article (PubMed ID: 24725174)
21. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
[TBL] [Abstract][Full Text] [Related]
22. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
23. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
24. FOXP3 in sequential biopsies of progressive mycosis fungoides.
Fried I; Cerroni L
Am J Dermatopathol; 2012 May; 34(3):263-5. PubMed ID: 22157245
[TBL] [Abstract][Full Text] [Related]
25. Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.
Kabasawa M; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Miyagaki T; Takahashi T; Shibata S; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol; 2016 Jul; 43(7):819-22. PubMed ID: 26825047
[TBL] [Abstract][Full Text] [Related]
26. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides.
Kallinich T; Muche JM; Qin S; Sterry W; Audring H; Kroczek RA
J Invest Dermatol; 2003 Nov; 121(5):1045-52. PubMed ID: 14708605
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides.
Pileri A; Agostinelli C; Righi S; Fuligni F; Bacci F; Sabattini E; Patrizi A; Pileri SA; Piccaluga PP
Histopathology; 2015 Jan; 66(2):173-81. PubMed ID: 24766213
[TBL] [Abstract][Full Text] [Related]
28. Expression and Cellular Localization of CXCR4 and CXCL12 in Human Carotid Atherosclerotic Plaques.
Merckelbach S; van der Vorst EPC; Kallmayer M; Rischpler C; Burgkart R; Döring Y; de Borst GJ; Schwaiger M; Eckstein HH; Weber C; Pelisek J
Thromb Haemost; 2018 Jan; 118(1):195-206. PubMed ID: 29304539
[TBL] [Abstract][Full Text] [Related]
29. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
30. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
31. COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
Kopp KL; Kauczok CS; Lauenborg B; Krejsgaard T; Eriksen KW; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N; Woetmann A
Leukemia; 2010 Jun; 24(6):1179-85. PubMed ID: 20428208
[TBL] [Abstract][Full Text] [Related]
32. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
33. Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections.
Nakajima R; Miyagaki T; Kamijo H; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
Eur J Dermatol; 2018 Dec; 28(6):790-794. PubMed ID: 30530405
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.
Rasheed H; Tolba Fawzi MM; Abdel-Halim MR; Eissa AM; Mohammed Salem N; Mahfouz S
Am J Dermatopathol; 2010 Apr; 32(2):162-9. PubMed ID: 20051814
[TBL] [Abstract][Full Text] [Related]
36. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
38. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.
Vacca A; Moretti S; Ribatti D; Pellegrino A; Pimpinelli N; Bianchi B; Bonifazi E; Ria R; Serio G; Dammacco F
Eur J Cancer; 1997 Sep; 33(10):1685-92. PubMed ID: 9389934
[TBL] [Abstract][Full Text] [Related]
39. [Significance of CXCL12/CXCR4 expression in T-lymphoblastic lymphoma/leukemia].
Yu ZZ; Xi YF; Li J; Bai WQ; Gao N; Bu P
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):838-843. PubMed ID: 28056298
[No Abstract] [Full Text] [Related]
40. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Murakami K; Miyake Y; Matsuo T
Clin Exp Immunol; 2005 Sep; 141(3):467-74. PubMed ID: 16045736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
